Experiences with
Upadacitinib25 public posts
Want to take advantage of all our features? Just log in!
or
ACR: Vaccinate patients with musculoskeletal, inflammatory, autoimmune disease for COVID-19
.), tofacitinib (Xeljanz, Pfizer) and upadacitinib (Rinvoq, AbbVie) — and some biologics — abatacept (Orencia, Bristol Myers Squibb) and rituximab (Rituxan, Genentech) — that alter the immune system’s response in ways that might affect vaccine response.